Literature DB >> 16199896

Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in pituitary adenomas.

Kyongsong Kim1, Daizo Yoshida, Akira Teramoto.   

Abstract

Hypoxia-inducible factor (HIF)-1alpha is a transcription factor in hypoxia adaptation mechanisms. In malignant tumors, HIF-1alpha upregulates vascular endothelial growth factor (VEGF) expression to induce tumor angiogenesis. Although VEGF and HIF-1alpha are expressed in pituitary adenomas, the relationships of these factors remain unclear. Therefore, we examined the expression of HIF-1alpha and VEGF using real-time RT-PCR and immunohistochemistry to clarify the relationship of these factors in pituitary adenomas. HIF-1alpha mRNA and VEGF mRNA levels in pituitary adenoma tissues from 25 operated patients were quantified using real-time RT-PCR. Some tissues were also studied by double fluorescent immunohistochemical methods. HIF-1alpha mRNA and protein were expressed in all pituitary adenomas examined. Their expression tended to be higher in GH-producing and lower in ACTH-producing tumors. VEGF mRNA and protein were also expressed in all pituitary adenomas. There was no significant correlation in the expression levels of HIF-1alpha and VEGF mRNA. The mutual expression of HIF-1alpha and VEGF was of no significance; in only a few cells were HIF-1alpha and VEGF co-localized. Our results suggest that in pituitary adenomas VEGF expression may not depend strongly on HIF-1alpha expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199896     DOI: 10.1385/ep:16:2:115

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  32 in total

Review 1.  Molecular events implicated in brain tumor angiogenesis and invasion.

Authors:  D Zagzag; D R Friedlander; B Margolis; M Grumet; G L Semenza; H Zhong; J W Simons; J Holash; S J Wiegand; G D Yancopoulos
Journal:  Pediatr Neurosurg       Date:  2000-07       Impact factor: 1.162

2.  Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro.

Authors:  P Lohrer; J Gloddek; U Hopfner; M Losa; E Uhl; U Pagotto; G K Stalla; U Renner
Journal:  Neuroendocrinology       Date:  2001-08       Impact factor: 4.914

Review 3.  Biological consequences of tumor hypoxia.

Authors:  M Höckel; P Vaupel
Journal:  Semin Oncol       Date:  2001-04       Impact factor: 4.929

4.  V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.

Authors:  B H Jiang; F Agani; A Passaniti; G L Semenza
Journal:  Cancer Res       Date:  1997-12-01       Impact factor: 12.701

5.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

Review 6.  Angiogenesis in pituitary adenomas.

Authors:  Shozo Yamada; Kouji Takada
Journal:  Microsc Res Tech       Date:  2003-02-01       Impact factor: 2.769

7.  Expression of vascular endothelial growth factor in human brain tumors.

Authors:  R Nishikawa; S Y Cheng; R Nagashima; H J Huang; W K Cavenee; M Matsutani
Journal:  Acta Neuropathol       Date:  1998-11       Impact factor: 17.088

8.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

Authors:  D M Brizel; S P Scully; J M Harrelson; L J Layfield; J M Bean; L R Prosnitz; M W Dewhirst
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

9.  The association of the expression of vascular endothelial growth factor with the cystic component and haemorrhage in pituitary adenoma.

Authors:  Shinji Fukui; Naoki Otani; Hiroshi Nawashiro; Akiko Yano; Namiko Nomura; Aya M Tokumaru; Takahito Miyazawa; Akira Ohnuki; Nobusuke Tsuzuki; Hiroshi Katoh; Shoichiro Ishihara; Katsuji Shima; Hidetoshi Ooigawa
Journal:  J Clin Neurosci       Date:  2003-05       Impact factor: 1.961

10.  Intratumoral oxygen pressure in malignant brain tumor.

Authors:  T Kayama; T Yoshimoto; S Fujimoto; Y Sakurai
Journal:  J Neurosurg       Date:  1991-01       Impact factor: 5.115

View more
  14 in total

1.  MRI-Based Radiomics: Nomograms predicting the short-term response after transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma patients with diameter less than 5 cm.

Authors:  Yani Kuang; Renzhan Li; Peng Jia; Wenhai Ye; Rongzhen Zhou; Rui Zhu; Jian Wang; Shuangxiang Lin; Peipei Pang; Wenbin Ji
Journal:  Abdom Radiol (NY)       Date:  2021-03-13

2.  Expression of laminin beta2: a novel marker of hypoxia in pituitary adenomas.

Authors:  Yijun Bao; Daizo Yoshida; Daijiro Morimoto; Akira Teramoto
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

3.  Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion.

Authors:  Teresa Gagliano; Carlo Filieri; Mariella Minoia; Mattia Buratto; Federico Tagliati; Maria Rosaria Ambrosio; Marcello Lapparelli; Matteo Zoli; Giorgio Frank; Ettore degli Uberti; Maria Chiara Zatelli
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

4.  Invasive giant prolactinoma with loss of therapeutic response to cabergoline: expression of angiogenic markers.

Authors:  María Susana Mallea-Gil; Carolina Cristina; María Inés Perez-Millan; Ana M Rodriguez Villafañe; Carolina Ballarino; Graciela Stalldecker; Damasia Becu-Villalobos
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

5.  Stromal cell-derived factor-1 expression in pituitary adenoma tissues and upregulation in hypoxia.

Authors:  Ryutaro Nomura; Daizo Yoshida; Akira Teramoto
Journal:  J Neurooncol       Date:  2009-03-12       Impact factor: 4.130

6.  Analysis of regulatory networks constructed based on gene coexpression in pituitary adenoma.

Authors:  Jie Gong; Bo Diao; Guo Jie Yao; Ying Liu; Guo Zheng Xu
Journal:  J Genet       Date:  2013-12       Impact factor: 1.166

Review 7.  Autophagy in normal pituitary and pituitary tumor cells and its potential role in the actions of somatostatin receptor ligands in acromegaly.

Authors:  Giovanni Tulipano; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2021-04-05       Impact factor: 6.514

8.  Expression of hypoxia-inducible factor-1α and vascular density in mammary adenomas and adenocarcinomas in bitches.

Authors:  Janusz A Madej; Jan P Madej; Piotr Dziegiel; Bartosz Pula; Marcin Nowak
Journal:  Acta Vet Scand       Date:  2013-10-24       Impact factor: 1.695

9.  Acute elevation of interleukin 6 and matrix metalloproteinase 9 during the onset of pituitary apoplexy in Cushing's disease.

Authors:  Takako Araki; Jutarat Sangtian; Darin Ruanpeng; Ramachandra Tummala; Brent Clark; Lynn Burmeister; Daniel Peterson; Andrew S Venteicher; Yasuhiko Kawakami
Journal:  Pituitary       Date:  2021-05-26       Impact factor: 4.107

10.  Identification of candidate genes for human pituitary development by EST analysis.

Authors:  Yueyun Ma; Xiaofei Qi; Jianjun Du; Shaojun Song; Dongyun Feng; Jia Qi; Zhidong Zhu; Xin Zhang; Huasheng Xiao; Zeguang Han; Xiaoke Hao
Journal:  BMC Genomics       Date:  2009-03-15       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.